½ÃÀ庸°í¼­
»óǰÄÚµå
1462834

¼¼°èÀÇ Åõ¼®±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Ç÷¾×Åõ¼®, º¹¸·Åõ¼®, Àåºñ, ¼Ò¸ðǰ, Áúȯ À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°, 2023-2030³â

Global Dialysis Machine Market Size study & Forecast, by Hemodialysis, Peritoneal Dialysis, Equipment, Consumables, Disease Type, End User, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Åõ¼®±â ½ÃÀåÀº 2022³â¿¡ ¾à 168¾ï 9,313¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ 2023- 2030³â¿¡´Â 4.6% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Åõ¼®Àº ½ÅÀå ±â´ÉÀÌ ÀúÇÏµÈ »ç¶÷, ÀϹÝÀûÀ¸·Î ¸¸¼º ½ÅºÎÀüÁõ ȯÀÚÀÇ Ç÷·ù¿¡¼­ ¿ä¼Ò¿Í Å©·¹¾ÆÆ¼´Ñ°ú °°Àº ³ëÆó¹°À» Á¦°ÅÇϱâ À§ÇØ »ç¿ëµÇ´Â Áß¿äÇÑ ÀýÂ÷ÀÔ´Ï´Ù. ÀÌ °úÁ¤Àº ¸»±â ½ÅºÎÀüÁõ(ESRD) Ä¡·á ¹× ½ÅÀå À̽ÄÀ» À§ÇÑ Áغñ ´Ü°è·Î¼­ ÇʼöÀûÀÔ´Ï´Ù. Åõ¼®Àº ÀüÇØÁú ±ÕÇüÀ» ȸº¹Çϰí Ç÷¾×À» Á¤È­Çϸç ü³»ÀÇ °úµµÇÑ ¼öºÐ°ú µ¶¼Ò¸¦ Á¦°ÅÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Ç÷¾× Åõ¼®°ú º¹¸· Åõ¼®Àº Åõ¼®¿¡ »ç¿ëµÇ´Â µÎ °¡Áö ÁÖ¿ä ¹æ¹ýÀÔ´Ï´Ù. Ç÷¾×Åõ¼®Àº ȯÀÚÀÇ Ç÷¾×¿¡¼­ ¿ä¼Ò¿Í °°Àº ³ëÆó¹°À» ü¿Ü·Î ¹èÃâÇÏ´Â ¹æ½ÄÀ̸ç, º¹¸·Åõ¼®Àº º¹ºÎÀÇ º¹¸·À» ÀÌ¿ëÇØ Åõ¼®À» ÇÏ´Â ¹æ½ÄÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¸¸¼º ½ÅÀå ÁúȯÀÇ À¯º´·ü Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ Á¤ºñ ¹× È®Ãæ µîÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¸¸¼ºÄáÆÏº´(CKD)ÀÇ À¯º´·ü Áõ°¡´Â Åõ¼®±â ½ÃÀå È®´ëÀÇ Áß¿äÇÑ Ã˸ÅÁ¦°¡ µÇ°í ÀÖÀ¸¸ç, CKD´Â Ãʱ⿡´Â ¹«Áõ»óÀÎ °æ¿ì°¡ ¸¹Àº ÁøÇ༺ ÁúȯÀ¸·Î Àü ¼¼°è¿¡¼­ »ó´çÇÑ ¼öÀÇ È¯ÀÚ¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Statista¿¡ µû¸£¸é 2021³â ¸»±â½ÅºÎÀü(ESRD) À¯º´·üÀº Àα¸ 100¸¸ ¸í´ç ¾à 2,219¸íÀ¸·Î 2001³â Àα¸ 100¸¸ ¸í´ç 1,644¸í¿¡¼­ Å©°Ô Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. Å©°Ô Áõ°¡Çß½À´Ï´Ù. ÀÌ Åë°è´Â 2,000-2021³â±îÁö ¹Ì±¹³» ESRD À¯º´·üÀÇ ÃßÀ̸¦ º¸¿©ÁÝ´Ï´Ù. ¶ÇÇÑ ¹Ì±¹¿¡¼­ ¸¸¼ºÄáÆÏº´(CKD) À¯º´·üÀº ³²¼ºº¸´Ù ¿©¼ºÀÌ ¾à°£ ´õ ³ôÀ¸¸ç, 2017-2020³â »çÀÌ CKD Áø´ÜÀ» ¹ÞÀº ¿©¼ºÀÇ ºñÀ²Àº 15.4%ÀÎ ¹Ý¸é ³²¼ºÀÇ ºñÀ²Àº 12.6%·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ CKD´Â 65¼¼ ÀÌ»ó ³ë³âÃþ¿¡¼­ ´õ ¸¹ÀÌ ¹ß»ýÇϸç, 65¼¼ ÀÌ»ó ȯÀÚ°¡ ´ëºÎºÐÀ» Â÷ÁöÇÕ´Ï´Ù. ±×·¯³ª Åõ¼® ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀ̰í Åõ¼® Ä¡·á¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

Åõ¼®±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå Á¡À¯À²°ú ¸ÅÃâ Ãø¸é¿¡¼­ Åõ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ÀÌ Áö¿ªÀÇ R&D ¿ª·®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Á¤ºÎ ±¸»ó È®´ë, °¢±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó °­È­¿¡ ±âÀÎÇÕ´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß Åõ¼®±â ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¿¡´Â ÀÇ·á ºÎ¹®¿¡ ´ëÇÑ Á¤ºÎ ÁöÃâ Áõ°¡, ±â¼ú ¹ßÀü, ÀÇ·á Á¢±Ù¼º ¹× ǰÁú Çâ»óÀ» À§ÇÑ Á¤ºÎ ÁÖµµ ±¸»óÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù¿¡¼­ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí, ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. Á¶»ç ´ë»ó±¹¿¡¼­ »ê¾÷ÀÇ ÁúÀû¡¤¾çÀû Ãø¸é ¾çÃøÀ» Æ÷ÇÔ½Ã۵µ·Ï ¼³°èµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ÇâÈÄ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀÎ ¹× °úÁ¦ µîÀÇ Áß¿äÇÑ Ãø¸é¿¡ °üÇÑ »ó¼¼ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ ¹× Á¦Ç° Á¦°øÀÇ »ó¼¼ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇϱâ À§ÇÑ ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³â
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå ¿ªÇÐ

  • Åõ¼®±â ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ¸¸¼º½ÅÀ庴ÀÇ À¯º´·ü Áõ°¡
      • °í·ÉÈ­ Àα¸ÀÇ Áõ°¡
      • ÀÇ·á ÀÎÇÁ¶óÀÇ Á¤ºñ¿Í È®´ë
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
      • Åõ¼® ¼­ºñ½º¿¡ ´ëÇÑ ¾×¼¼½º Á¦ÇÑ
      • Åõ¼® Ä¡·á¿¡ ¼ö¹ÝÇÏ´Â °íºñ¿ë
    • ½ÃÀå ±âȸ
      • ¿þ¾î·¯ºí Åõ¼® ±â¼úÀÇ °³¹ß
      • ½ÅÈï ½ÃÀå¿¡ ´ëÇÑ ÁøÃâ

Á¦4Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five Forces ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • Àú°¡°Ý
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð¡¤Á¦¾È

Á¦5Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Ç÷¾×Åõ¼®º°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Ç÷¾×Åõ¼®º°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Ç÷¾×Åõ¼®º° 2020-2030³â ÃßÁ¤¡¤¿¹Ãø
  • Åõ¼®±â ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ±âÁ¸Çü Ç÷¾×Åõ¼®
    • ´Ü½Ã°£ Ç÷¾×Åõ¼®
    • ¾ß°£ Ç÷¾×Åõ¼®

Á¦6Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : º¹¸·Åõ¼®º°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : º¹¸·Åõ¼®º°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : º¹¸·Åõ¼®º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • Åõ¼®±â ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Áö¼ÓÀû ¿Ü·¡ º¹¸·Åõ¼®
    • ÀÚµ¿ º¹¸·Åõ¼®

Á¦7Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Àåºñº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Àåºñº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Àåºñº°, ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Åõ¼®±â
    • ¼öó¸® ½Ã½ºÅÛ
    • ±âŸ

Á¦8Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : ¼Ò¸ðǰº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : ¼Ò¸ðǰº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : ¼Ò¸ðǰº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • Åõ¼®±â ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • Åõ¼®±â
    • Ä«Å×ÅÍ
    • ±âŸ

Á¦9Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Áúȯ À¯Çüº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Áúȯ À¯Çüº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : Áúȯ À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • Åõ¼®±â ½ÃÀåÀÇ ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¸¸¼º
    • ±Þ¼º

Á¦10Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû¡¤ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • Åõ¼®±â ½ÃÀåÀÇ ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • Ŭ¸®´Ð
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ȨÄɾî

Á¦11Àå ¼¼°èÀÇ Åõ¼®±â ½ÃÀå, Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ¼¼°èÀÇ Åõ¼®±â ½ÃÀå, Áö¿ªº° ½ÃÀå ½º³À¼ô
  • ºÏ¹Ì
    • ¹Ì±¹
      • Ç÷¾×Åõ¼®º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • º¹¸·Åõ¼®º°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • Àåºñº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¼Ò¸ðǰº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • Áúȯ À¯Çüº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ Åõ¼®±â ½ÃÀå ½º³À¼ô
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Åõ¼®±â ½ÃÀå ½º³À¼ô
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Åõ¼®±â ½ÃÀå ½º³À¼ô
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Diaverum(½º¿þµ§)
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
    • Baxter(¹Ì±¹)
    • B. Melsungen AG(µ¶ÀÏ)
    • BD(¹Ì±¹)
    • Cantel Medical(¹Ì±¹)
    • DaVita Inc.(¹Ì±¹)
    • Dialife(½ºÀ§½º)
    • Fresenius Medical Care AG & Co. KGaA(µ¶ÀÏ)
    • Isopure Corp.(¹Ì±¹)
    • Medtronic(¾ÆÀÏ·£µå)

Á¦13Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç ÀüÁ¦Á¶°Ç
KSA 24.04.30

Global Dialysis Machine Market is valued approximately USD 16893.13 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.6% over the forecast period 2023-2030. Dialysis is a vital procedure utilized to eliminate waste substances such as urea and creatinine from the bloodstream in individuals with compromised kidney function, typically those suffering from chronic renal failure. This process is essential in the treatment of end-stage renal disease (ESRD) and as a preparatory step for kidney transplantation. Dialysis is crucial in restoring electrolyte balance, purifying the blood, and eliminating excess fluid and toxins from the body. Hemodialysis and peritoneal dialysis are the two primary methods employed for dialysis. Hemodialysis involves the extracorporeal removal of waste substances like urea from the patient's blood, while peritoneal dialysis utilizes the peritoneum in the abdomen for dialysis. The market growth is driven by key factors such as the increasing prevalence of chronic kidney disease, the growing aging population, and the development and expansion of healthcare infrastructure.

The rising incidence of chronic kidney disease (CKD) serves as a key catalyst for the expansion of the dialysis machines market. CKD, a progressive condition often asymptomatic in its early stages, impacts a substantial number of individuals worldwide. Multiple factors contribute to the escalating burden of CKD, including the increasing prevalence of conditions like diabetes and hypertension. As per Statista, in 2021, the prevalence of end-stage renal disease (ESRD) reached approximately 2,219 cases per one million population, marking a significant rise from the rate of 1,644 per one million population observed in 2001. This statistic illustrates the trajectory of prevalent ESRD cases in the U.S. from 2000 to 2021. Furthermore, in the United States, chronic kidney disease (CKD) is marginally more prevalent among females than males, with 15.4 percent of females diagnosed with CKD during the period from 2017 to 2020, in contrast to 12.6 percent of males. Additionally, CKD is more commonly observed in older individuals, with the majority of cases occurring among those aged 65 years and older. However, limited access to dialysis services, and high cost associated with dialysis treatment stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Dialysis Machine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the regional growth of dialysis machines market, both in terms of market share and revenue, throughout the forecast period from 2023 to 2030. This dominance is attributed to the region's heightened investment in research and development capabilities, expanding government initiatives, and enhanced healthcare infrastructure across various countries. Meanwhile, the Asia-Pacific region is projected to witness the highest growth rate in the dialysis machines market during the forecast period from 2023 to 2030. This growth is fueled by increased government expenditure on the healthcare sector, advancements in technology, and government-led initiatives aimed at enhancing healthcare accessibility and quality.

Major market player included in this report are:

  • Diaverum (Sweden)
  • Baxter (U.S.)
  • B. Melsungen AG (Germany)
  • BD (U.S.)
  • Cantel Medical (U.S.)
  • DaVita Inc. (U.S)
  • Dialife (Switzerland)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Isopure Corp. (U.S.)
  • Medtronic (Ireland)

Recent Developments in the Market:

  • In November 2021, Fresenius Medical Care unveiled innovative digitalized solutions aimed at empowering patients with end-stage kidney disease to undergo dialysis conveniently from their residences. These offerings include the 5008S hemodialysis (HD) machine and a novel automated peritoneal dialysis (APD) machine.

Global Dialysis Machine Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Haemodialysis, Peritoneal Dialysis, Equipment, Consumable, Disease Type, End-Users, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Hemodialysis:

  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis

By Peritoneal Dialysis:

  • Continuous Ambulatory Peritoneal Dialysis
  • Automated Peritoneal Dialysis

By Equipment:

  • Dialysis Machines
  • Water Treatment Systems
  • Others

By Consumables:

  • Dialyzers
  • Catheters
  • Others

Disease Type:

  • Chronic
  • Acute

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Setting

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1.Dialysis Machine Market, by Region, 2020-2030 (USD Million)
    • 1.2.2.Dialysis Machine Market, by Haemodialysis, 2020-2030 (USD Million)
    • 1.2.3.Dialysis Machine Market, by Peritoneal Dialysis, 2020-2030 (USD Million)
    • 1.2.4.Dialysis Machine Market, by Equipment, 2020-2030 (USD Million)
    • 1.2.5.Dialysis Machine Market, by Consumable, 2020-2030 (USD Million)
    • 1.2.6.Dialysis Machine Market, by Disease Type, 2020-2030 (USD Million)
    • 1.2.7.Dialysis Machine Market, by End-user, 2020-2030 (USD Million)
    • 1.2.8.
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Dialysis Machine Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Dialysis Machine Market Dynamics

  • 3.1.Dialysis Machine Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing prevalence of chronic kidney disease
      • 3.1.1.2.Growing aging population
      • 3.1.1.3.Development and expansion of healthcare infrastructure
    • 3.1.2.Market Challenges
      • 3.1.2.1.Limited access to dialysis services
      • 3.1.2.2.High cost associated with dialysis treatment
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Development of wearable dialysis technology
      • 3.1.3.2.Expansion into emerging markets

Chapter 4.Global Dialysis Machine Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Dialysis Machine Market, by Haemodialysis

  • 5.1.Market Snapshot
  • 5.2.Global Dialysis Machine Market by Haemodialysis, Performance - Potential Analysis
  • 5.3.Global Dialysis Machine Market Estimates & Forecasts by Haemodialysis 2020-2030 (USD Million)
  • 5.4.Dialysis Machine Market, Sub Segment Analysis
    • 5.4.1.Conventional Hemodialysis
    • 5.4.2.Short Daily Hemodialysis
    • 5.4.3.Nocturnal Hemodialysis

Chapter 6.Global Dialysis Machine Market, by Peritoneal Dialysis

  • 6.1.Market Snapshot
  • 6.2.Global Dialysis Machine Market by Peritoneal Dialysis, Performance - Potential Analysis
  • 6.3.Global Dialysis Machine Market Estimates & Forecasts by Peritoneal Dialysis 2020-2030 (USD Million)
  • 6.4.Dialysis Machine Market, Sub Segment Analysis
    • 6.4.1.Continuous Ambulatory Peritoneal Dialysis
    • 6.4.2.Automated Peritoneal Dialysis

Chapter 7.Global Dialysis Machine Market, by Equipment

  • 7.1.Market Snapshot
  • 7.2.Global Dialysis Machine Market by Equipment, Performance - Potential Analysis
  • 7.3.Global Dialysis Machine Market Estimates & Forecasts by Equipment 2020-2030 (USD Million)
  • 7.4.Dialysis Machine Market, Sub Segment Analysis
    • 7.4.1.Dialysis Machines
    • 7.4.2.Water Treatment Systems
    • 7.4.3.Others

Chapter 8.Global Dialysis Machine Market, by Consumable

  • 8.1.Market Snapshot
  • 8.2.Global Dialysis Machine Market by Consumable, Performance - Potential Analysis
  • 8.3.Global Dialysis Machine Market Estimates & Forecasts by Consumable 2020-2030 (USD Million)
  • 8.4.Dialysis Machine Market, Sub Segment Analysis
    • 8.4.1.Dialyzers
    • 8.4.2.Catheters
    • 8.4.3.Others

Chapter 9.Global Dialysis Machine Market, by Disease Type

  • 9.1.Market Snapshot
  • 9.2.Global Dialysis Machine Market by Disease Type, Performance - Potential Analysis
  • 9.3.Global Dialysis Machine Market Estimates & Forecasts by Disease Type 2020-2030 (USD Million)
  • 9.4.Dialysis Machine Market, Sub Segment Analysis
    • 9.4.1. Chronic
    • 9.4.2.Acute

Chapter 10.Global Dialysis Machine Market, by End-user

  • 10.1.Market Snapshot
  • 10.2.Global Dialysis Machine Market by End-user, Performance - Potential Analysis
  • 10.3.Global Dialysis Machine Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
  • 10.4.Dialysis Machine Market, Sub Segment Analysis
    • 10.4.1. Hospitals
    • 10.4.2.Clinics
    • 10.4.3.Ambulatory Surgical Centers
    • 10.4.4.Home Care Setting

Chapter 11.Global Dialysis Machine Market, Regional Analysis

  • 11.1.Top Leading Countries
  • 11.2.Top Emerging Countries
  • 11.3.Dialysis Machine Market, Regional Market Snapshot
  • 11.4.North America Dialysis Machine Market
    • 11.4.1.U.S. Dialysis Machine Market
      • 11.4.1.1.Hemodialysis breakdown estimates & forecasts, 2020-2030
      • 11.4.1.2.Peritoneal Dialysis breakdown estimates & forecasts, 2020-2030
      • 11.4.1.3.Equipment breakdown estimates & forecasts, 2020-2030
      • 11.4.1.4.Consumable breakdown estimates & forecasts, 2020-2030
      • 11.4.1.5.Disease Type breakdown estimates & forecasts, 2020-2030
      • 11.4.1.6.End-user breakdown estimates & forecasts, 2020-2030
    • 11.4.2.Canada Dialysis Machine Market
  • 11.5.Europe Dialysis Machine Market Snapshot
    • 11.5.1.U.K. Dialysis Machine Market
    • 11.5.2.Germany Dialysis Machine Market
    • 11.5.3.France Dialysis Machine Market
    • 11.5.4.Spain Dialysis Machine Market
    • 11.5.5.Italy Dialysis Machine Market
    • 11.5.6.Rest of Europe Dialysis Machine Market
  • 11.6.Asia-Pacific Dialysis Machine Market Snapshot
    • 11.6.1.China Dialysis Machine Market
    • 11.6.2.India Dialysis Machine Market
    • 11.6.3.Japan Dialysis Machine Market
    • 11.6.4.Australia Dialysis Machine Market
    • 11.6.5.South Korea Dialysis Machine Market
    • 11.6.6.Rest of Asia Pacific Dialysis Machine Market
  • 11.7.Latin America Dialysis Machine Market Snapshot
    • 11.7.1.Brazil Dialysis Machine Market
    • 11.7.2.Mexico Dialysis Machine Market
  • 11.8.Middle East & Africa Dialysis Machine Market
    • 11.8.1.Saudi Arabia Dialysis Machine Market
    • 11.8.2.South Africa Dialysis Machine Market
    • 11.8.3.Rest of Middle East & Africa Dialysis Machine Market

Chapter 12.Competitive Intelligence

  • 12.1.Key Company SWOT Analysis
  • 12.2.Top Market Strategies
  • 12.3.Company Profiles
    • 12.3.1. Diaverum (Sweden)
      • 12.3.1.1.Key Information
      • 12.3.1.2.Overview
      • 12.3.1.3.Financial (Subject to Data Availability)
      • 12.3.1.4.Product Summary
      • 12.3.1.5.Recent Developments
    • 12.3.2. Baxter (U.S.)
    • 12.3.3.B. Melsungen AG (Germany)
    • 12.3.4.BD (U.S.)
    • 12.3.5.Cantel Medical (U.S.)
    • 12.3.6.DaVita Inc. (U.S)
    • 12.3.7.Dialife (Switzerland)
    • 12.3.8.Fresenius Medical Care AG & Co. KGaA (Germany)
    • 12.3.9.Isopure Corp. (U.S.)
    • 12.3.10.Medtronic (Ireland)

Chapter 13.Research Process

  • 13.1.Research Process
    • 13.1.1.Data Mining
    • 13.1.2.Analysis
    • 13.1.3.Market Estimation
    • 13.1.4.Validation
    • 13.1.5.Publishing
  • 13.2.Research Attributes
  • 13.3.Research Assumption
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦